Privia Health Group, Inc.
PRVANasdaqCIK 1759655HealthcareFiscal year ends Dec 31
Reports and events: 100 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-0814:48 ET | SCHEDULE 13D | Ownership report, active investor | 0000950103-26-013658 |
| 2026-08-1809:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001759655-26-000068 |
| 2026-08-0608:45 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001759655-26-000064 |
| 2026-08-0606:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-26-000061 |
| 2026-07-0716:09 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001759655-26-000056 |
| 2026-05-2208:00 ET | 8-K | 5.07 Shareholder vote results | 0001759655-26-000034 |
| 2026-05-0708:58 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001759655-26-000029 |
| 2026-05-0706:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-26-000027 |
| 2026-04-0207:55 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0001193125-26-138997 |
| 2026-02-2708:12 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001759655-26-000010 |
| 2026-02-2606:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-26-000007 |
| 2025-12-0808:01 ET | 8-K | 8.01 Other events | 0001759655-25-000113 |
| 2025-11-0608:45 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001759655-25-000110 |
| 2025-11-0606:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-25-000108 |
| 2025-10-2817:11 ET | 8-K | 8.01 Other events | 0001759655-25-000104 |
| 2025-09-2316:12 ET | 8-K | 8.01 Other events | 0001759655-25-000099 |
| 2025-08-2917:49 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-25-000096 |
| 2025-08-0709:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001759655-25-000093 |
| 2025-08-0706:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-25-000091 |
| 2025-07-0809:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001759655-25-000080 |
| 2025-05-2216:03 ET | 8-K | 5.07 Shareholder vote results | 0001759655-25-000056 |
| 2025-05-0809:01 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001759655-25-000050 |
| 2025-05-0806:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-25-000048 |
| 2025-04-0409:00 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0001193125-25-072922 |
| 2025-03-0708:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001759655-25-000023 |
| 2025-02-2708:54 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001759655-25-000018 |
| 2025-02-2706:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-25-000016 |
| 2025-01-1308:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-25-000004 |
| 2024-11-0708:52 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001759655-24-000131 |
| 2024-11-0706:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-24-000129 |
| 2024-08-0808:53 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001759655-24-000117 |
| 2024-08-0806:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-24-000115 |
| 2024-07-0309:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001759655-24-000110 |
| 2024-06-0507:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-24-000106 |
| 2024-05-2916:06 ET | 8-K/A | 5.07 Shareholder vote results | 0001759655-24-000099 |
| 2024-05-2316:20 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001759655-24-000076 |
| 2024-05-0908:44 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001759655-24-000052 |
| 2024-05-0906:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-24-000050 |
| 2024-04-0416:14 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0001193125-24-087256 |
| 2024-02-2716:16 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001759655-24-000022 |
| 2024-02-2706:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-24-000019 |
| 2024-01-2908:52 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-24-000011 |
| 2024-01-0808:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001759655-24-000004 |
| 2023-11-2109:04 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001759655-23-000216 |
| 2023-11-0309:01 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001759655-23-000211 |
| 2023-11-0306:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-23-000209 |
| 2023-08-0316:06 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001759655-23-000190 |
| 2023-08-0306:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001759655-23-000186 |
| 2023-07-3109:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001759655-23-000181 |
| 2023-06-2909:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001759655-23-000138 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 12:37 ET. Listed shows no prices and gives no investment advice.